As the FDA weighs its first psychedelic approval, Sarah Norman, MPP, says training, credentialing, and reimbursement are lagging while patients are already asking.
News|Articles|May 30, 2024
Learn about the procedure that saved Maverick.
Advertisement
Dr. Emile Bacha, Director of Congenital Pediatric Cardiac Surgery at NewYork‑Presbyterian Morgan Stanley Children's Hospital, collaborated with a multidisciplinary team of specialists to repair a complex case of "Swiss Cheese" septum.
Advertisement
Related to this article
Pranav Garimella discusses what a potential USPSTF kidney screening recommendation could mean for high-risk adults and primary care.
Andrea Murina, MD, weighs whether she would recommend medicine to her own children amid AI, physician burnout, and evolving residency training standards.
Two monoclonal antibodies isolated from malaria-exposed donors blocked patient IgE from binding key alpha-gal allergens and suppressed basophil activation.
Manju Dawkins, MD, discusses Skin Angels, why clinicians belong in dermatology innovation, and her work to reduce injection pain and needle anxiety.
As the USPSTF considers evidence for updated CKD screening guidance, Garimella discusses gaps in kidney disease detection and what the review should capture.
Discover how newly cleared weekly basal insulin efsitora reshapes type 2 diabetes care—QWINT results, hypoglycemia edge, and dosing tips.
FDA clears Eli Lilly’s Onswik weekly insulin from QWINT trials, cutting injections for type 2 diabetes while matching daily basal control.
Advertisement
Advertisement
Trending on HCPLive
1
The Case for Routine Kidney Screening, With Pranav Garimella, MBBS, MPH
2
Anti-Alpha-Gal Antibodies Block IgE Binding in Alpha-Gal Syndrome
3
Nearly 9 in 10 US Adults With CKD Don't Know They Have It, With Pranav Garimella
4
Weekly Insulin Efsitora Alfa (Onswik) Gains FDA approval for Type 2 Diabetes
5